Drug intelligence / Profile preview

Argivit

Development stage
Unknown
Lead developer
Ceres Pharma
Modality
Small Molecules
Administration
Oral
01

Overview

Argivit is a multi-ingredient dietary supplement developed by Ceres Pharma, specifically through its Italian subsidiary Aesculapius Farmaceutici, designed to provide comprehensive energy and nutritional support. The formulation is a combination of small molecule active ingredients including L-arginine, creatine, L-carnitine, and L-aspartic acid, supplemented with magnesium pidolate, potassium citrate, and a variety of vitamins and minerals. It is primarily indicated for counteracting physical and mental tiredness, supporting muscle function, and maintaining energy metabolism during periods of high demand, seasonal changes, or physical activity. The product line includes specialized versions such as Argivit Focus and Argivit Smart, which are tailored for cognitive support and rapid energy recovery, respectively.

Brand names
ArgivitArgivit FocusArgivit Smart
Other names
Argivit Classic
02

Targets

CPT1 (Carnitine palmitoyltransferase family)NOS1 (nNOS)

Beyond the preview

Go deeper on Argivit.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Argivit.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call